Status:
COMPLETED
Examination of B Cell Responses in Human Blood
Lead Sponsor:
Regenerative Medicine Network
Collaborating Sponsors:
University of Leipzig
Conditions:
HIV Infections
Eligibility:
All Genders
18-65 years
Brief Summary
The aim of this study is the assessment B-cell immune responses in HIV-infected individuals.
Detailed Description
Groups of patients with different immune competencies will be examined. The impact of HIV infection on immune response will be assessed.
Eligibility Criteria
Inclusion
- HIV-infected individuals
- controls
Exclusion
- \- none
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00806845
Start Date
July 1 2008
End Date
February 1 2010
Last Update
May 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universität Leipzig
Leipzig, Saxony, Germany, 04103